Long-Term Follow-Up of 1,654 Consecutive Non-Hodgkin Lymphoma Patients – Data from a Single Institution

1995 ◽  
Vol 18 (3) ◽  
pp. 231-239
Author(s):  
R. Heinz ◽  
A. Fortelny ◽  
B. Schneider ◽  
G. Hopfinger ◽  
N. Worel ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Single Institution ◽  
Non Hodgkin Lymphoma ◽  
Long Term Follow Up

scholarly journals Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive Non-Hodgkin Lymphoma (NHL): Long-Term Follow-up of the Pivotal Zuma-1 Trial

2018 ◽  
Vol 24 (3) ◽  
pp. S74-S75 ◽  
Author(s):  
Sattva S. Neelapu ◽  
Frederick L. Locke ◽  
Nancy L. Bartlett ◽  
Lazaros J. Lekakis ◽  
David Miklos ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Non Hodgkin Lymphoma ◽  
Long Term Follow Up

scholarly journals OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

2018 ◽  
Vol 10 (1) ◽  
pp. e2018020 ◽  
Author(s):  
Paola Angelini ◽  
Laura Rodriguez ◽  
Mohammed Zolaly ◽  
Ahmed Naqvi ◽  
Sheila Weitzman ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Hodgkin Lymphoma ◽  
Survival Rates ◽  
Age At Diagnosis ◽  
Single Institution ◽  
Non Hodgkin Lymphoma ◽  
Sick Children ◽  
The Impact

Background: The incidence and biology of non-Hodgkin lymphoma (NHL) vary according to age. Some data suggest that the impact of age in pediatric and adolescent NHL patients depends on the histological subtype. Objectives: We aimed to analyze the impact of age at diagnosis on clinical characteristics and treatment-related toxicity in children and adolescents with NHL.Methods: Retrospective review of medical records of children and adolescents diagnosed with NHL at the Hospital for Sick children, Toronto, between January 1995 and December 2008.Results: 164 children were diagnosed with NHL during the study period, with a median age at diagnosis of 10 years. With a median follow-up of 6.2 years, 5-year OS in patients aged <15 and 15-18 years was 89± 2% vs 82% ± 6%, respectively (P = 0.30), and 5-year EFS was 84% ± 3% vs. 77% ± 7%  (P= 0.37). In Burkitts lymphoma (BL) and lymphoblastic lymphoma (LL) there was a trend towards better outcomes in children compared to adolescents, with EFS of  91% ± 4% vs. 75% ± 15%, respectively in BL (P= 0.17),  and 82% ± 7% vs. 51.4% ± 2% respectively in LL (P= 0.16). Late effects occurred in 21 patients (12.8%).Conclusions: Children with NHL aged < 15 years tend to have better survival rates and less long-term toxicity than adolescents aged 15-18 years.

scholarly journals Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase 1, First-in-Human Study

2021 ◽  
pp. clincanres.4842.2020
Author(s):  
Matthew S. Davids ◽  
Andrew W. Roberts ◽  
Vaishalee P. Kenkre ◽  
William G. Wierda ◽  
Abhijeet Kumar ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Phase 1 ◽  
Human Study ◽  
Non Hodgkin Lymphoma ◽  
Long Term Follow Up

scholarly journals Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone

Cancer ◽  
2004 ◽  
Vol 100 (2) ◽  
pp. 350-355 ◽  
Author(s):  
Fausto Rossini ◽  
Elisabetta Terruzzi ◽  
Daniele Perego ◽  
Isabella Miccolis ◽  
Franca Rivolta ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
High Grade ◽  
Non Hodgkin Lymphoma ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document